Hayden F G, Rollins B S, Madren L K
Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville 22908.
Antiviral Res. 1994 Oct;25(2):123-31. doi: 10.1016/0166-3542(94)90101-5.
The anti-influenza activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en (4-G-NAc) was determined in Madin-Darby canine kidney (MDCK) cells by yield reduction and ELISA and in explants of human respiratory epithelium by yield reduction. In MDCK cells, 50% inhibitory concentrations (EC50) averaged 0.5 microgram/ml for influenza A/Virginia/88(H3N2) and 0.04 microgram/ml for A/Texas/36/91(H1N1) by ELISA, and < 0.01 microgram/ml for influenza A/Virginia by yield reduction. In human adenoid explants, concentrations causing at least 1.0 log10 TCID50/ml decrease in yield (EC90) at 48 h were < 0.01 microgram/ml for A(H1N1) and A(H3N2) viruses and 0.25 microgram/ml for B/Hong Kong/5/72. 100 micrograms/ml 4-G-NAc did not inhibit outgrowth of human adenoid epithelium at 6 days, whereas ribavirin 10 micrograms/ml reduced outgrowth by > 50%. 4-G-NAc is a potent and selective inhibitor of clinical isolates of influenza A and B viruses in human respiratory epithelium.
通过产量降低法和酶联免疫吸附测定法(ELISA)在犬肾传代细胞(MDCK)中,以及通过产量降低法在人呼吸道上皮外植体中测定了神经氨酸酶抑制剂4-胍基-Neu5Ac2en(4-G-NAc)的抗流感活性。在MDCK细胞中,通过ELISA法测定,甲型流感病毒/弗吉尼亚/88(H3N2)的50%抑制浓度(EC50)平均为0.5微克/毫升,甲型流感病毒/得克萨斯/36/91(H1N1)为0.04微克/毫升;通过产量降低法测定,甲型流感病毒/弗吉尼亚的EC50<0.01微克/毫升。在人腺样体外植体中,48小时时使产量至少降低1.0 log10 TCID50/毫升(EC90)的浓度,对于甲型(H1N1)和甲型(H3N2)病毒<0.01微克/毫升,对于乙型流感病毒/香港/5/72为0.25微克/毫升。100微克/毫升的4-G-NAc在6天时不抑制人腺样体上皮的生长,而10微克/毫升的利巴韦林使生长减少>50%。4-G-NAc是人类呼吸道上皮中甲型和乙型流感病毒临床分离株的一种强效且选择性的抑制剂。